+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Boronic Acids 1082525-64-1
1082525-64-1,MFCD12922967
Catalog No.:AA008T87

1082525-64-1 | 1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$14.00   $10.00
- +
1g
95%
in stock  
$90.00   $63.00
- +
5g
95%
in stock  
$402.00   $281.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008T87
Chemical Name:
1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
CAS Number:
1082525-64-1
Molecular Formula:
C18H25BN2O3
Molecular Weight:
328.2137
MDL Number:
MFCD12922967
SMILES:
CC1(C)OB(OC1(C)C)c1ccc2c(c1)cnn2C1CCCCO1
Properties

Downstream Synthesis Route
1631-26-1    1082525-64-1   
1-benzyl-3-1-(tetrahydro-pyran-2-yl)-1H-indazol-5-yl-pyrrolidine-2,5-dione 

[1]Locationinpatent:schemeortableBannwart,LindaM.;Carter,DavidS.;Cai,Hai-Ying;Choy,JasonC.;Greenhouse,Robert;Jaime-Figueroa,Saul;Iyer,PravinS.;Lin,ClaraJ.;Lee,EunKyung;Lucas,MatthewC.;Lynch,StephenM.;Madera,AnnMarie;Moore,Amy;Ozboya,Kerem;Raptova,Lubica;Roetz,Ralf;Schoenfeld,RyanC.;Stein,KarinAnn;Steiner,Sandra;Villa,Marzia;Weikert,RobertJ.;Zhai,Yansheng[BioorganicandMedicinalChemistryLetters,2008,vol.18,#23,p.6062-6066]

[1]Locationinpatent:bodytextCrestey,François;Lohou,Elodie;Stiebing,Silvia;Collot,Valérie;Rault,Sylvain[Synlett,2009,#4,p.615-619]

5-bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole 
  73183-34-3    1082525-64-1 

[1]Locationinpatent:experimentalpartCrestey,François;Lohou,Elodie;Stiebing,Silvia;Collot,Valérie;Rault,Sylvain[Synlett,2009,#4,p.615-619]

[2]CurrentPatentAssignee:SPHAERAPHARMA-WO2014/16849,2014,A2Locationinpatent:Page/Pagecolumn119;121

[3]Savage,Scott;McClory,Andrew;Zhang,Haiming;Cravillion,Theresa;Lim,Ngiap-Kie;Masui,Colin;Robinson,SarahJ.;Han,Chong;Ochs,Christoph;Rege,PankajD.;Gosselin,Francis[JournalofOrganicChemistry,2018,vol.83,#19,p.11571-11576]

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2009/115427,2009,A1Locationinpatent:Page/Pagecolumn37-38

[5]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24021,2017,A1Locationinpatent:Paragraph0613;0615;0728;0729

[6]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24013,2017,A1Locationinpatent:Paragraph0613;0615

[7]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/24010,2017,A1Locationinpatent:Paragraph0613;0615;0656;0657

[8]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-WO2017/23986,2017,A1Locationinpatent:Paragraph0617;0619

[9]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/60326,2017,A1Locationinpatent:Page/Pagecolumn34;35

[10]CurrentPatentAssignee:BAYERAG-WO2019/149637,2019,A1Locationinpatent:Page/Pagecolumn230;231

[1]CurrentPatentAssignee:MCGILLUNIVERSITY-WO2011/147038,2011,A1Locationinpatent:Page/Pagecolumn59-60

[1]CurrentPatentAssignee:SPHAERAPHARMA-WO2014/16849,2014,A2

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1082525-64-1
956388-05-9

956388-05-9

 1562245-02-6

1562245-02-6

 1146955-35-2

1146955-35-2

 1158680-98-8

1158680-98-8

 1698028-42-0

1698028-42-0

 2072805-66-2

2072805-66-2
Building Blocks
More >
Tags:1082525-64-1 Molecular Formula|1082525-64-1 MDL|1082525-64-1 SMILES|1082525-64-1 1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole